RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 11.28

Change

+0.40 (+3.68)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.58 (+1.37%)

USD 0.95B
SOXS Direxion Daily Semiconductor B..

+2.28 (+9.98%)

USD 0.66B
PSQ ProShares Short QQQ

+0.94 (+2.47%)

USD 0.61B
SPXU ProShares UltraPro Short S&P50..

+0.87 (+3.93%)

USD 0.51B
SDOW ProShares UltraPro Short Dow30

+1.00 (+2.11%)

USD 0.29B
YANG Direxion Daily FTSE China Bear..

-1.30 (-1.59%)

USD 0.17B
SPDN Direxion Daily S&P 500® Bear ..

+0.14 (+1.28%)

USD 0.14B
RWM ProShares Short Russell2000

+0.29 (+1.60%)

USD 0.14B
DOG ProShares Short Dow30

+0.19 (+0.73%)

USD 0.13B
DUST Direxion Daily Gold Miners Ind..

+1.05 (+1.62%)

USD 0.10B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.45% 95% A 19% F
Dividend Return 3.50% 68% D+ 56% F
Total Return -1.95% 95% A 20% F
Trailing 12 Months  
Capital Gain -16.94% 91% A- 10% F
Dividend Return 3.97% 60% D- 52% F
Total Return -12.97% 91% A- 11% F
Trailing 5 Years  
Capital Gain -70.56% 67% D+ 5% F
Dividend Return 2.64% 68% D+ 8% B-
Total Return -67.92% 67% D+ 4% F
Average Annual (5 Year Horizon)  
Capital Gain 56.85% 40% F 94% A
Dividend Return 57.91% 40% F 94% A
Total Return 1.05% 55% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 422.94% 62% D 3% F
Risk Adjusted Return 13.69% 42% F 31% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.